Control of glycoprotein synthesis. IX. A terminal Manα1-3Manβ1- sequence in the substrate is the minimum requirement for UDP-N-acetyl-D-glucosamine:α-D- mannoside (GlcNAc to Manα1-3) β2-N-acetylglucosaminyltransferase I

Author:

Vella George J.,Paulsen Hans,Schachter Harry

Abstract

Twenty low molecular weight compounds were tested as substrates for UDP-GlcNAc:α-D-mannoside (GlcNAc to Manα1-3) β2-N-acetylglucosammyltransferase I (GlcNAc-transferase I) purified from bovine colostrum. This enzyme is at a key control point in the biosynthetic path leading to complex Asn-linked oligosaccharides. The highest activity was obtained with the substrate Manα1-3(R1α1-6)Manβ1-R2 where R1 was Manα1-3(Manα1-6)Man- (Km = 0.20 mM) and R2 was -4GlcNAcβ1-4GlcNAc-Asn. Somewhat less effective were substrates in which R1 was Man- (Km = 0.4–0.6 mM) and R2 was either -4GlcNAc or -4GlcNAcβ1-4(Fucα1-6)GlcNAc-Asn. Removal of the Manα1-6 arm (R1 = H-) or replacing R2 with an isopropyl group had no effect on Vmax but increased the Km about 10-fold, thereby leading to an 85% reduction in enzyme activity as measured under standard conditions. An 85% reduction in activity was also observed if R2 was replaced with N-acetylglucosaminitol. Enzyme activity was reduced 33% if R1 was Galβ1-4GlcNAcβ1-2Man-. Any compounds lacking a Manα1-3- terminus or in which the β-linked Man had been replaced with an α-linked Man were totally inactive. It was concluded that a terminal Manα1-3Manβ1-sequence is a minimal structural requirement for a GlcNAc-transferase I substrate. The only effective substrate for partially purified UDP-GlcNAc:α-D-mannoside (GlcNAc to Manβ1-6) β2-N-acetylglucosaminyltransferase II (GlcNAc-transferase II) from bovine colostrum was R1GlcNAcβ1-2Manα1-3(Manα1-6)Manβ1-R2 where R1 = H-. The absence of a terminal GlcNAcβ1-2- residue or masking this residue by making R1 = Galβ1-4-, both prevented enzyme activity, indicating that GlcNAc-transferase I action must precede GlcNAc-transferase II action during biosynthesis of complex Asn-linked oligosaccharides.

Publisher

Canadian Science Publishing

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3